This company has been acquired
Chembio Diagnostics Management
Management criteria checks 2/4
Key information
Richard Eberly
Chief executive officer
US$1.6m
Total compensation
CEO salary percentage | 28.6% |
CEO tenure | 3.1yrs |
CEO ownership | 1.0% |
Management average tenure | 2.2yrs |
Board average tenure | 2.6yrs |
Recent management updates
Recent updates
Chembio gets $3.2M contract from CDC to develop rapid test for syphilis
Sep 06Chembio stock rises 13% amid plans to develop rapid test for monkeypox
Aug 16Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt In A Risky Way?
Nov 30Analysts' Revenue Estimates For Chembio Diagnostics, Inc. (NASDAQ:CEMI) Are Surging Higher
Aug 08Does Chembio Diagnostics (NASDAQ:CEMI) Have A Healthy Balance Sheet?
Jul 22Chembio Diagnostics EPS beats by $0.10, beats on revenue
May 06Is Chembio Diagnostics (NASDAQ:CEMI) Using Debt Sensibly?
Apr 07Is Chembio Diagnostics, Inc.'s (NASDAQ:CEMI) Shareholder Ownership Skewed Towards Insiders?
Jan 16Chembio stock gains after COVID-19 tests nab European Union nod
Jan 14Is Chembio Diagnostics (NASDAQ:CEMI) Weighed On By Its Debt Load?
Dec 12Chembio slumps 13% on delay of U.S. nod for coronavirus antibody test
Dec 04Chembio nabs BARDA contract for rapid respiratory antigen panel test
Dec 02CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2022 | US$2m | US$460k | -US$23m |
Sep 30 2022 | n/a | n/a | -US$36m |
Jun 30 2022 | n/a | n/a | -US$36m |
Mar 31 2022 | n/a | n/a | -US$38m |
Dec 31 2021 | US$2m | US$477k | -US$34m |
Sep 30 2021 | n/a | n/a | -US$27m |
Jun 30 2021 | n/a | n/a | -US$26m |
Mar 31 2021 | n/a | n/a | -US$25m |
Dec 31 2020 | US$1m | US$315k | -US$26m |
Compensation vs Market: Richard's total compensation ($USD1.61M) is above average for companies of similar size in the US market ($USD767.83K).
Compensation vs Earnings: Richard's compensation has been consistent with company performance over the past year.
CEO
Richard Eberly (61 yo)
3.1yrs
Tenure
US$1,610,406
Compensation
Mr. Richard L. Eberly serves as the President and Chief Executive Officer at Chembio Diagnostics, Inc. since March 16, 2020 and has been its Director since May 02, 2020. He joined Chembio in March, 2020. H...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 3.1yrs | US$1.61m | 1.03% $ 171.6k | |
Executive VP | 1.3yrs | US$1.05m | 0.15% $ 24.4k | |
Executive VP and Chief Scientific & Technology Officer | 19.3yrs | US$765.96k | 0.50% $ 84.2k | |
Executive VP & COO | 3yrs | no data | 0.021% $ 3.6k | |
Vice President of Human Resources | 1.4yrs | no data | no data | |
Senior Vice President of Global Commercial Operations | 1.3yrs | no data | 0.021% $ 3.6k |
2.2yrs
Average Tenure
59yo
Average Age
Experienced Management: CEMI's management team is considered experienced (2.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.9yrs | US$1.61m | 1.03% $ 171.6k | |
Independent Director | less than a year | US$143.43k | no data | |
Independent Director | 4.9yrs | US$100.31k | 0.15% $ 24.6k | |
Independent Chairperson | 15.9yrs | US$123.89k | 0.31% $ 52.0k | |
Independent Director | 2.3yrs | US$91.56k | 0.040% $ 6.7k | |
Independent Director | 2.1yrs | US$94.06k | 0.031% $ 5.2k |
2.6yrs
Average Tenure
64yo
Average Age
Experienced Board: CEMI's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.